Treatment Trials for Prostate Cancer
Mar-02-2007
Trials launched to tackle killer prostate cancer
A two-year trial of treatments for prostate cancer is to begin at
Newcastle and two other universities to tackle a disease that kills about 8,500 men a year.
Prostate Cancer & You: Dr Charles "Snuffy" Myers Symposium
Mar-02-2007
The Foundation For Cancer Research and Education announced today that renowned prostate oncologist and prostate cancer survivor, Dr.
Thalidomide may slow some prostate cancers
Mar-02-2007
The drug thalidomide may slow the progression of prostate cancer in some
patients, according to premiminary research led by Dr Marcus Drake of
the School of Surgical & Reproductive Sciences.
Reactions To 'False-positive' Prostate Cancer Screenings Assessed
Mar-02-2007
Science Daily - Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent ...
Green tea found to slow prostate cancer growth
Mar-01-2007
Researchers from University of Wisconsin-Madison have found that a component of green tea, combined with low doses of Pfizer's COX-2 inhibitor Celebrex, could slow the spread of human prostate cancer.
Reactions to 'false-positive' prostate cancer screenings assessed
Mar-01-2007
Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results.
Tea Antioxidant Plus Celebrex May Fight Prostate Cancer
(HealthDay)
Mar-02-2007
HealthDay - FRIDAY, March 2 (HealthDay News) -- A component of green tea,
combined with low doses of the cox-2 inhibitor painkiller Celebrex, may be
able to slow prostate cancer growth, according to a U.S. study.
Active Surveillance Underutilized in Prostate Cancer
Mar-02-2007
Data from a US national registry suggest that 16% of men diagnosed with prostate cancer have low-risk disease, but only 9% of these choose active surveillance instead of immediate treatment.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Cytogen initiates prostate cancer study
Mar-01-2007
Cytogen Corporation has initiated a phase II study to evaluate Quadramet in combination with the therapeutic vaccine, PSA-TRICOM for patients with prostate cancer.
Tea Antioxidant Plus Celebrex May Fight Prostate Cancer
Mar-02-2007
A component of green tea, combined with low doses of the cox-2 inhibitor painkiller Celebrex, may be able to slow prostate cancer growth, according to a U.S. study.
Dendreon drug goes to FDA
Mar-01-2007
U.S. regulators assigned a review of Dendreon Corp.'s experimental prostate cancer treatment to a committee of experts on cell and gene therapies.
?13m for prostate campaign
Mar-02-2007
Ministers will today launch a ?13m drive to find an effective treatment against prostate cancer. Newcastle, Sheffield and Bristol universities are leading the seven year study involving 230,000 men
Drug Cuts Men's Prostate Risk
Mar-02-2007
June 24 - Scientists have discovered that a drug that shrinks enlarged prostates and fights baldness also cuts men's chances of getting prostate cancer.
Hume Cronyn Dead At 91
Mar-02-2007
June 17 - Hume Cronyn, the Canadian-born actor who graced the stage and silver screen for 70-years, died of prostate cancer. Cronyn was 91-years-old.
Dendreon says FDA to review Provenge submission
Mar-01-2007
Dendreon Corporation has said the FDA will review the biologics license application for Provenge, its investigational active cellular immunotherapy for the treatment of prostate cancer.